To define the risk factors related to the occurrence of fungemia in children infected with human immunodeficiency virus (HIV), we performed a matched case-control study. During a 6-year period (1987)(1988)(1989)(1990)(1991)(1992)(1993), fungemia developed in 22 (6.3%)of 347 HIV-infected children observed at the Pediatric Branch of the National Cancer Institute. Each of these 22 cases was matched by age and gender with three controls. Multiple logistic regression indicated that the best predictor of fungemia in this population was the presence of a central venous catheter placed for >90 days (P < .00001),followed by a group of risk factors composed of 10 independent variables adjusted for a CD4 cell count of < 1001f-LL (P < .045). Those variables included treatment with more than three antibiotics, treatment with more than three parenteral antibiotics, > 30 days of antibiotic treatment, bacterial infections, >30 days in the hospital, hypoalbuminemia, C3 (Centers for Disease Control and Prevention) classification of HIV infection, and malnourishment. We conclude that prolonged placement of central venous catheters is the most important risk factor for fungemia in HIV-infected children and that the risk of fungemia is further influenced by antibacterial therapy, catheter manipulation, and host response.
Fungemia is a common cause of morbidity and mortality in immunocompromisedchildren,includingthose with cancer, organ transplant recipients, and very low birth weight infants [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . In most of the reported large series of cases [11] [12] [13] [14] [15] [16] , fungemia presented as a nosocomiallyacquired infectionwith a high mortality rate; major independentrisk factors associated with this condition included prior antibiotic therapy, presence of intravascular catheters, parenteral hyperalimentation, hemodialysis, colonization by Candida species, and prolonged neutropenia.
We recently reported 22 cases of fungemia in 347 HIYinfected children who were observed prospectively at the Pediatric Branch of the National Cancer Institute [17] . Fungemia in this cohort developed predominantly as a community-acquired infection, was caused by non-Candida albicans fungal species in one-half of the cases, and was associated with a high survival rate (95%). These epidemiologic, pathogenic, and prognostic features differ from those of other pediatric immunocompromised populations. However, little is known about the risk factors that contribute to the development of fungemia in HIYinfected children. To further define the risk factors related to this infection, we performed a matched case-control study.
Patients and Methods

Patient Population and Case Definition
Between 1987 and 1993, fungemia developed in 22 (6.3%) of 347 HIY-infected children who were observed at the Pediatric Branch of the National Cancer Institute at the Warren Grant Magnuson Clinical Center. All patients were diagnosed with HIY infection on the basis of the presence of antibodies detected by ELISA and western blotting or on the basis of the detection of HIV type 1 p24 antigen. Viral culture or nucleic acid detection with PCR analysis was also performed for selected patients. Patients were categorized according to the Centers for Disease Control and Prevention (CDC) classification of HIY infection in children younger than 13 years of age and adolescents [18, 19] . Absolute lymphocyte, CD4 cell, and CD8 cell counts were compared with known standards [20] [21] [22] .
A case was defined as a patient for whom at least one or more blood cultures were positive for a fungus. All patients who met the case definition were included in the study. Each of these cases was then matched by age and sex with three HIY-infected controls. Thus, 22 cases and 66 matched controls were studied.
Microbiological Techniques
Cultures of blood specimens routinely drawn from central venous catheters (CYCs) and peripheral venous sites were performed with use of Isolator lysis centrifugation (Wampole Laboratories, Cranbury, NJ) and the BACTEC System (Johnston Laboratories, Towson, MD). Since 1991, the BacT Alert method (Organon Teknika, Durham, NC) was also used to perform blood cultures. To detect fungi, blood from the lysis centrifugation tubes was inoculated onto horse blood agar, chocolate agar, yeast differential agar, Sabouraud glucose agar, and cysteine-glucose agar.
Study Design
A matched case-control study was performed to study the chosen potential risk factors and their relationship with em 1996; 23 (September) fungemia in the pediatric population of patients with AIDS. Each case was matched with three controls. The matched variables included sex and age. There was a difference ofno greater than 1.55 ± 0.7 months in age between the cases and their controls. The 6-month period before the diagnosis of fungemia in the cases was defined as the interval during which all data were collected. The same corresponding interval was used for each respective matched control in an attempt to avoid bias in exposure to potential risk factors.
Information Reviewed
A total of 49 potential risk factors were studied through a retrospective review of the patients' medical records in the 6-month interval before the date of the diagnosis of fungemia. Records from the clinical microbiology laboratory, outpatient clinic charts, and, when applicable, records from other hospitals caring for these patients served as further sources of information. The potential risk factors were classified in eight groups: immunologic and virological features ofHIV infection, hospital admissions, clinical course of HIV infection, presence ofCVCs or other catheters, antiretroviral therapy, antimicrobial therapy, other medications, and laboratory analyses.
These variables were further stratified as follows: immunologic and virological features of HIV infection-CDC classification of HIV infection, p24 antigen level, absolute CD4 cell and CD8 cell counts, and CD4 cell/CD8 cell ratio; hospital admissions-number ofhospital admissions (recorded as none, one to three, and more than three) and number of hospital days (classified as 0, 1-30, and >30 days); clinical course of HIV infection-malnourishment and fungal infections (oropharyngeal candidiasis [OPC] or esophageal candidiasis, cryptococcosis, and Pneumocystis carinii pneumonia) or bacterial infections (bacteremia, Mycobacterium avium complex infection, and other life-threatening infections including meningitis, pneumonia, osteomyelitis, septic arthritis, and abscesses of a body cavity or internal organ); presence of CVCs or other catheters-type of CVC, nasogastric tube, urinary catheter, endotracheal tube, and duration of placement of catheter; antiretroviral therapy-agent(s) (including zidovudine, didanosine, zalcitabine, lamivudine, and combination therapies) and route of administration (oral or intravenous [continuous infusion of zidovudinej); antimicrobial therapy-route of administration (oral or parenteral), the number of antibiotics (stratified as none, one to three, and more than three), and the duration (stratified as 0, 0-4, and >4 weeks) (antifungal therapy was stratified only by the type of antifungal agents); other medications-granulocyte colony-stimulating factor, corticosteroids, antacid therapy, and total parenteral nutrition (TPN); and laboratory analyses-neutropenia «500/mm 3 ) and hypoalbuminemia «3 g/dL).
All variables were recorded in a dichotomous fashion as present (yes) or absent (no). The total number of variables studied was 5,368, and 5,339 were fulfilled for a success rate of 99.5%. The only variables that could not be retrieved were complete information on p24 antigen level, CD4 cell count, and CD4 cell/CD8 cell ratio for the patients during the interval observed.
Statistical Analysis
The score test of the conditional logistic regression model for matched case-control data was used for the univariate analyses. Because of the large number of tests performed, we considered only those variables with P values of <.001 as significant. The maximum likelihood estimate of the logistic regression coefficient was calculated for each variable. The relative risk for a variable was estimated by the exponentiation of this maximum likelihood estimate. In the multivariate analysis, the P values for individual variables were also based on the score statistic evaluated with the maximum likelihood estimate of the adjusted variables. The usual procedure is to adjust for the most significant variable. This procedure could not be performed with our data because all the cases presented with the most significant risk factor (CVC). Therefore, another significant risk factor (CD4 cell count of < 1001J.LL) was the adjusted variable in the multivariate analysis.
Results
During the 6-year study period (1987) (1988) (1989) (1990) (1991) (1992) (1993) , fungemia developed in 22 (6.3%) of 347 HIV-infected children. There were 14 male cases (64%) and eight female cases (36%). The mean age of the cases was 4.5 years (range, 8 months to 13 years). Eighteen (82%) of the cases acquired HIV infection by the vertical route, and four (18%) acquired HIV infection by transfusion of blood products. Each case with fungemia was matched to three controls. The demographic and HIV-related epidemiologic features of cases and controls are detailed in table 1. There was a difference of no greater than 1.55 ± 0.7 months in age between cases and their respective controls. While the route of acquisition of HIV infection was not a factor considered in the matching, cases and controls were coincident regarding this variable, possibly because of the close matching in age. Sex, in the case of patients with hemophilia, also accounted for the coincidence in the acquisition of HIV infection.
Fungemia developed in association with chronically indwelling CVCs in the setting of TPN (27%), continuous infusion of zidovudine (36%), or intravenous antibiotic therapy for proven bacterial infections (77%). Candida albicans was the most common pathogen isolated from blood cultures, accounting for 48% of the episodes; other fungal species, including Candida parapsilosis, Candida tropicalis, Candida krusei, Torulopsis glabrata, Rhodotorula rubra, and Bipolaris species, constituted the other one-half of the isolates causing fungemia (table 2). All of these organisms were recovered from cultures of blood drawn through the CVC and less frequently (41%) from cultures of blood drawn through CVCs and from peripheral sites because of the new onset of fever. No patient had fungemia * Two fungi were simultaneously recovered from blood specimens from two patients during a single episode of fungemia: C. krusei plus T. glabrata and R. rubra plus C. parapsilosis, respectively. detectable only by cultures of blood drawn from a peripheral site.
A total of 49 variables were analyzed; the frequency of these variables in cases and controls is described in table 3. In the univariate analyses (table 4), a P value of <.001 was chosen to select the most significant variables. The strongest (P < .00001) risk factors for fungemia were the presence of a CVC and a period of >90 days after its placement. CVCs were present in every patient in whom fungemia developed and in only 20% of the controls. The relative risk of this variable is large and cannot be estimated because all cases presented with a CVe.
Other highly significant risk factors (P = .00002-.00003) included a CD4 cell count of <1001,uL (RR, 9.9), treatment with more than three oral or parenteral antibiotics (RR, 8) Several other statistically significant variables had P values ranging from .0002 to .001. The number of hospital days and the total number of days of antibiotic treatment were significant (RR, 7.64, and RR, 6.62, respectively) only when the third level of stratification (>30 days) was used in the comparison, thus reflecting the community-acquired nature of most cases of fungemia in the patients. C3 (CDC) classification of HIV infection (RR, 8.51), continuous infusion of zidovudine (RR, 7.41), malnourishment (RR, 6.33), and hypoalbuminemia (RR, 18) also were significantly related to fungemia, further implicating the role of impaired cellular immunity in predisposing individuals to candidiasis. Neutropenia was rare in our patients. The univariate analysis of TPN showed an imbalance between cases and controls, but this imbalance was not large enough to be called significant by our stringent criterion in this study.
The presence of a CVC had the smallest P value; however, since all cases presented with CVCs, they could not be used in the multivariate analysis as the adjusted variable. A low absolute CD4 cell count « 100/,uL), factors related to antibiotic therapy, and bacterial infections were other variables with strong significance in the univariate analyses. Since a CD4 cell count is the most reliable predictor of clinically relevant immune deficiency in HIV-infected patients, we chose it as the variable by which to run multiple logistic regression.
The adjustment of the other variables for an absolute CD4 cell count of < 100 ,u1L increased most of their P values by factors of 10 to 100, thereby indicating their correlation with the CD4 cell count. Eleven of 49 variables were still significantly and independently associated with an increased risk of development of fungemia after the adjustment ( Fungemia is an increasingly common problem in severely ill pediatric patients with cancer, pediatric transplant recipients, and very-low-birth-weight neonates [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] 15] . Recently, fungemia (with a relatively high frequency of 7%) also has been described in the pediatric population of HIV-infected patients [17, [23] [24] [25] . Fungemia in HIV-infected children in these three parenteral antibiotics (P = .0018), >30 days of antibiotic treatment (P = .0028), bacterial infections (P = .0073) including bacteremia (P = .0031) and M avium complex infection (P = .012), >30 days in the hospital (P = .017), hypoalbuminemia (P = .04), CDC classification of HIV infection of C3 (P = .041), and malnourishment (P = .045). studies presented as both community-acquired and nosocomial infections, was frequently due to newly emerging opportunistic fungi, and was associated with a good prognosis if it was diagnosed early and treated promptly. The study reported herein was conducted to determine the most important risk factors associated with fungemia in this new pediatric population of immunocompromised patients. Forty-nine potential risk factors were studied, which analyzed 22 cases closely matched with 66 controls. Several risk factors identified in the univariate analyses have been previously reported in the literature, while others were specially related to HIV disease, including type of immunosuppression and antiretroviral therapy [11] [12] [13] [14] . The strongest (P < .0001) detected risk factors were presence of a eve, eve placement for >90 days, treatment with more than three parenteral antibiotics, duration of antibiotic therapy of > 30 days, absolute eD4 cell count of < 100/p,L, and continuous infusion of zidovudine.
These findings suggest a model for introduction of fungal pathogens through the eve that is secondary to repeated and protracted manipulations. Once fungi are introduced into the bloodstream, the profound impairment of cellular immunity may prevent clearance of fungal elements and result in detectable fungemia,
The presence of a eve and antibiotic therapy have been previously addressed as risk factors in case-control studies of neonates and patients with cancer [11, 12] . Neither of these prior studies reported duration of eve placement or duration of parenteral antibiotic therapy as important risk factors for their respective populations. Both duration of eve placement and duration of antibiotic therapy along with the number of antibiotics used and continuous infusion of zidovudine were strong variables in our study, thus underscoring the importance of catheter manipulation in the development of fungemia.
Immunodeficiency of the host-including profound neutropenia, corticosteroid therapy, and prematurity (which is associated with multiple immune defects)-is another clear risk fac- tor for fungemia. To our knowledge, our study is the first to investigate the risk factors for fungemia in an HIV-infected population. The incidence of neutropenia in our population was very low. Conversely, a profound impairment in cellular immunity, measured by an absolute eD4 cell count, was found to be a strong variable. Children as well as adults with AIDS are frequently affected by OPC or esophageal candidiasis [26] [27] [28] [29] [30] . Moreover, mucosal candidiasis is the most common fungal infection in patients with AIDS and can affect up to 70%--100% of patients. Chronic oral colonization with Candida species has been reported. In a prospective observational study of92 HIV-infected adults, Sangeorzan et a1. [29] demonstrated that 84% of the patients were colonized with yeast. This study [29] and a later study [30] also found that patients were usually colonized with a single Candida strain and that ope or recurrent ope was generally due to that same strain. A paucity of data regarding oral colonization with Candida species in HIV-infected children is available in the literature, but limited data indicate that the rate of colonization in children can be as high as that in adults [26, 27] .
Colonization of peripheral sites-such as skin, oral mucosa, intestinal tract, and respiratory tract-has been identified as an independent risk factor of fungernia in neonates, bone marrow transplant recipients, neutropenic hosts, and critically ill patients [12, [31] [32] [33] [34] . Karabinis et a1. [11] reported that colonization of even one peripheral site by a strain of Candida increases the risk of systemic infection in patients with cancer. By comparison, a positive oral culture in our study was a weakly related variable (P = .027) in this respect. Fourteen (64%) of the cases and 25 (38%) of the controls had microbiologically documented ope due to C. albicans, which was the most frequent cause of fungemia. Few patients had associated esophageal disease during the study period.
A relatively high percentage (77%) of the cases and almost one-half (45%) of the controls received a form of long-term antifungal therapy (mainly oral azoles) for either treatment or prevention of OPC. One can infer that the absence of neutropenia and more intact mucosal surfaces in patients with AIDS may account for the differences in the impact of candida colonization on the development of fungemia.
The fact that fungemia developed during the course of ketoconazole or fluconazole treatment suggests that antifungal therapy for ope provides minimal protection for the catheter. This lack of protection against fungi is possibly because of low dosages of the drug, poor bioavailability in the case of ketoconazole, or intermittent dosing schedules. Higher dosages of azoles may suppress bloodstream infection.
Several studies [34] [35] [36] [37] have determined a strong association between oral candidiasis and reduced CD4+ cell count and function. Normal T cell count and function appear to be critical in limiting proliferation of C. albicans in the gastrointestinal tract and in clearing C. albicans from the gastrointestinal tract. Although conditions are favorable for mucosal colonization and disease due to Candida in the HIV-infected population, ern 1996; 23 (September) our findings suggest that dissemination from the gastrointestinal tract appears to be infrequent. This observation is consistent with in vivo studies of mice with gastrointestinal candidiasis and severe cell-mediated immunosuppression [38] [39] [40] [41] , in whom no dissemination from the gastrointestinal tract was detected.
The use of TPN was relatively infrequent in our pediatric population with AIDS and was administered predominantly to ambulatory patients. By comparison, TPN has been shown to be an important independent risk factor for fungemia in different severely ill hospitalized pediatric patients [12, 15] . Outbreaks of C. parapsilosts fungemia in intensive care units have been associated with the use ofTPN [42] [43] [44] . The hospital environment and higher rates of catheter manipulation in critically ill patients are important factors in the association of TPN with fungemia; the frequency of these factors was low in our study of mostly ambulatory patients.
Isolation of a fungus from one or more blood cultures was considered significant for disease in all cases except one with bipolaris fungemia. Two earlier cultures of blood from this patient yielded Bipolaris species that were thought to be contaminants until progressive respiratory distress developed and another set of cultures of blood from the CVC was positive. As discussed by Edwards [45] , a blood culture positive for Candida species should be considered clinically significant, and in virtually all cases, the patient should be treated. The sequelae of untreated candidemia include endophthalmitis, arthritis,osteomyelitis,and renal candidiasis. Consequently, we considered every episode of fungemia to be clinically significant.
The univariate analyses identified seven statistically significant (P < .0001) risk factors for fungemia in our HIV-infected children. While each variable may be used individually to assess the likelihood of fungemia in this population, the discriminant multivariate analysis provides a more quantitative basis on which factors have the best discriminating power.
The presence of a eve persisted as the dominant risk factor after applying multiple logistic regression with a CD4 cell count of < 100/J.lL as the adjusted variable. In the pediatric literature, the presence of a CVC has not only been identified as a strong risk factor for fungemia but also as a fundamental factor in the outcome of disease if it is not removed promptly [46, 47] . These vascular catheters, which were present in all of the cases, may have served as a portal of entry for fungi from cutaneous surfaces or from the inanimate environment.
The respective P values of the other variables, after adjusting for a CD4 cell count of < 100/J.lL, increased by factors of 10 to 100, but these variables remained as significant independent risk factors.
In conclusion, the results of our matched case-control study show that children who have advanced HIV infection and a CVC have the highest risk of fungemia complicating their course of disease.
